WASHINGTON, Sept. 18 -- Federal Aviation Administration has issued a rule called: Airworthiness Directives; Rolls-Royce Deutschland Ltd. & Co. KG Engines. The rule was published in the Federal Regist... Read More
WASHINGTON, Sept. 18 -- Department Of Energy has issued a rule called: Energy Conservation Program: Energy Conservation Standards for Manufactured Housing. The rule was published in the Federal Regis... Read More
WASHINGTON, Sept. 18 -- Agricultural Marketing Service has issued a rule called: Milk in the Northeast and Other Marketing Areas; Uniform Pricing Formula Provisions. The rule was published in the Fed... Read More
Tokyo, Sept. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062966) titled 'A Study on the Efficacy of TF-CBT for Trauma-Related Disorders Caused by D... Read More
Tokyo, Sept. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062950) titled 'Effects of 15-minute water walking in a hydrogen pool on blood flow' on Se... Read More
Tokyo, Sept. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059153) titled 'Clinical Study of Psychological Impact of Food Ingredients: a placebo-cont... Read More
Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132785) titled 'A Qualitative Study on the Home Competence Experience of Primiparous Wom... Read More
Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132788) titled 'Effect of Visualized Non-inflatable Laryngeal Mask Airway on Ventilatory... Read More
Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132792) titled 'Impact and Mechanism of Gastric Acid on the Efficacy of Endoscopic Ultra... Read More
Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132796) titled 'Ipilimumab/Tuvonralimab Combined with FOLFOXIRI and Targeted Therapy for... Read More